AllianceBernstein’s Verona Pharma VRNA Stock Holding History

AllianceBernstein’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-718,343	Closed	-$76.7M	–	3308
2025 Q3	$76.7M	Buy	718,343 +596,752	+491%	+$62.3M	0.02%	502
2025 Q2	$11.5M	Buy	121,591 +24,227	+25%	+$1.79M	﹤0.01%	1112
2025 Q1	$6.18M	Buy	+97,364	New	+$5.82M	﹤0.01%	1370

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

AllianceBernstein's VRNA Position: Q4 2025 in Review

AllianceBernstein sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 718,343 shares — an estimated $76.7M sold.

AllianceBernstein first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $76.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

AllianceBernstein reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
AllianceBernstein sold 718,343 Verona Pharma shares in Q4 2025, an estimated $76.7M.
AllianceBernstein first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
AllianceBernstein's Verona Pharma position peaked at $76.7M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on AllianceBernstein's 13F filing for Q4 2025, filed 17 Feb 2026.